The adult epilepsy market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan)…
Read More
Artificial Intelligence Unlocks Hidden Brain Patterns for Earlier Epilepsy Diagnosis
Researchers at the University of Delaware (UD), in collaboration with Nemours Children’s Health, are harnessing the power of artificial intelligence…
Read More
Precision DNA Editing Targets Root Cause of Severe Childhood Epilepsy in Preclinical Study
A groundbreaking preclinical study led by researchers at The Jackson Laboratory (JAX; ME, USA) has successfully utilized precision gene editing…
Read More
Precision DNA editing targets root cause of severe childhood epilepsy in a preclinical study.
In a landmark preclinical study, researchers from The Jackson Laboratory (JAX; Bar Harbor, ME, USA), in collaboration with the Broad…
Read More
UCB Acquires Neurona Therapeutics for Up to $1.15 Billion to Bolster Epilepsy Pipeline with Regenerative Cell Therapy
BRUSSELS, BELGIUM & SAN FRANCISCO, USA – April 20, 2026 – Global biopharmaceutical leader UCB has finalized a definitive agreement…
Read More
New drug cuts seizures by up to 91% in children with rare epilepsy
In a landmark development for pediatric neurology, an international clinical trial has demonstrated that an experimental genetic therapy, zorevunersen, can…
Read More
